Spectrum Asset Management (California)’s Medtronic MDT Stock Holding History

Spectrum Asset Management (California)’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.16M	Buy	36,227 +45	+0.1%	+$4.31K	1.01%	34
2025 Q4	$3.5M	Sell	36,182 -4,885	-12%	-$475K	1.17%	31
2025 Q3	$3.94M	Buy	41,067 +130	+0.3%	+$11.9K	1.39%	28
2025 Q2	$3.6M	Sell	40,937 -124	-0.3%	-$10.5K	1.56%	26
2025 Q1	$3.72M	Sell	41,061 -233	-0.6%	-$20.9K	1.65%	25
2024 Q4	$3.33M	Buy	41,294 +840	+2%	+$72.7K	1.49%	26
2024 Q3	$3.67M	Sell	40,454 -12	-0%	-$1.01K	1.55%	24
2024 Q2	$3.21M	Sell	40,466 -57	-0.1%	-$4.67K	1.49%	23
2024 Q1	$3.56M	Sell	40,523 -39,966	-50%	-$3.41M	1.53%	23
2023 Q4	$6.69M	Sell	80,489 -1,055	-1%	-$80.4K	2.96%	7
2023 Q3	$6.45M	Buy	81,544 +54,178	+198%	+$4.54M	3.39%	6
2023 Q2	$2.43M	Sell	27,366 -554	-2%	-$47.7K	1.21%	31
2023 Q1	$2.27M	Buy	27,920 +7,830	+39%	+$638K	1.12%	32
2022 Q4	$1.58M	Sell	20,090 -23,245	-54%	-$1.88M	0.76%	39
2022 Q3	$3.53M	Buy	43,335 +12,552	+41%	+$1.13M	1.81%	12
2022 Q2	$2.78M	Buy	30,783 +2,730	+10%	+$277K	1.37%	19
2022 Q1	$3.11M	Buy	28,053 +7,395	+36%	+$781K	1.22%	24
2021 Q4	$2.14M	Sell	20,658 -6,673	-24%	-$773K	0.6%	51
2021 Q3	$3.43M	Sell	27,331 -705	-3%	-$91.2K	1.05%	25
2021 Q2	$3.48M	Sell	28,036 -600	-2%	-$75.3K	1.04%	26
2021 Q1	$3.38M	Sell	28,636 -715	-2%	-$83.8K	1.04%	26
2020 Q4	$3.44M	Buy	29,351 +3,905	+15%	+$430K	1.23%	20
2020 Q3	$2.64M	Buy	25,446 +1,040	+4%	+$104K	1.11%	21
2020 Q2	$2.24M	Buy	24,406 +7,300	+43%	+$700K	1.16%	22
2020 Q1	$1.54M	Buy	17,106 +8,386	+96%	+$892K	1.47%	21
2019 Q4	$989K	Buy	+8,720	New	+$957K	0.55%	58
2016 Q4	–	Sell	-11,940	Closed	-$1.03M	–	64
2016 Q3	$1.03M	Sell	11,940 -280	-2%	-$24.4K	1.11%	23
2016 Q2	$1.06M	Buy	+12,220	New	+$988K	1.25%	19
2015 Q3	–	Sell	-13,165	Closed	-$976K	–	57
2015 Q2	$976K	Hold	13,165	–	–	0.84%	34
2015 Q1	$1.03M	Buy	+13,165	New	+$998K	0.91%	31

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Spectrum Asset Management (California)'s MDT Position: Q1 2026 in Review

Spectrum Asset Management (California) increased its Medtronic (MDT) stake by 0.12% in Q1 2026, buying an estimated $4.31K and bringing the position to 36,227 shares worth $3.16M. The position accounts for 1.01% of the portfolio, ranked #34.

Spectrum Asset Management (California) first reported a position in MDT in Q1 2015 and has held it in 30 quarters since. The position peaked at $6.69M in Q4 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Spectrum Asset Management (California) held 36,227 shares of Medtronic worth $3.16M as of Q1 2026.
Spectrum Asset Management (California) bought 45 Medtronic shares in Q1 2026, an estimated $4.31K.
Medtronic made up 1.01% of Spectrum Asset Management (California)'s portfolio in Q1 2026, its #34 holding.
Spectrum Asset Management (California) first reported a position in Medtronic in Q1 2015 and has held it in 30 quarters since.
Spectrum Asset Management (California)'s Medtronic position peaked at $6.69M in Q4 2023.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Spectrum Asset Management (California)'s 13F filing for Q1 2026, filed 22 Apr 2026.